Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS MONTH'S ISSUE:
July 2014

Do Children Taking SGAs Get Metabolic Monitoring?
Careful monitoring of adverse effects of psychotropic drugs in general and second-generation antipsychotics in particular falls below recommended standards for children and adolescents.

A New Treatment for Parkinson Disease Psychosis
In a placebo-controlled study of patients with Parkinson disease and psychosis, the 5-HT-2A receptor inverse agonist pimavanserin improved psychotic symptoms and did not worsen motor signs.

Ramelteon (Rozerem) to Prevent Delirium?
Preliminary results from using the melatonin-receptor agonist ramelteon (Rozerem) in hospitalized patients to prevent delirium are encouraging.

In Brief
Starting Dose of Eszopiclone Lowered to Avoid Next-Day Impairment; Study Examines Determinants of Antipsychotic Treatment Response

Anxiolytics, Hypnotics, and Mortality Risk
In a retrospective cohort study, a significant association was found between the use of anxiolytic and hypnotic drugs and an increased risk of death.

Biological Therapies in Psychiatry Newsletter written by Alan J. Gelenberg, MD
For over 30 years,
the source for
up-to-date information on psychotropic medications and other biological treatments for mental disorders


Concise.
Unbiased.
Informative.

Dr. Alan Gelenberg's Blog
BTP BLOG
Dr. Gelenberg’s thoughts on psychiatry today… and where it’s headed in the future.
BTP Gift Subscriptions
GIFT SUBSCRIPTIONS
Order and receive 3 bonus issues added to your own subscription as our thanks.
Activate Free Online Access for Residents
RESIDENTS: FREE ACCESS
Register now, or if you are completing your residency and received a promotional mailing, enter your code.

Subscribe to BTP
SUBSCRIBE
Subscribing to BTP is easy! You can receive the print version with online access, or online only.


BTP Subscriber Quote
"With time as tight as it is, I really appreciate the sheer volume of material that you review and summarize for us. You provide a tremendous service to busy clinicians like me and those we serve. Thanks again!"

- J. Rutherford, M.D.